Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...

Margaret Stevens, chair of the Great Ayton Cancer Research volunteer group, has dedicated decades to helping raise funds to ...

King Charles shared his cancer diagnosis in February 2024 after undergoing a procedure for an enlarged prostate and has received treatment that will be 'reduced' in 2026. Here's everything to know ...

Investing.com -- Actinium Pharmaceuticals Inc (NYSE:ATNM) stock rose 3.7% on Friday following the presentation of new preclinical data for its breast cancer therapy candidate ATNM-400 at the 2025 San ...

The British monarch gave his first extensive public comments about his cancer journey since being diagnosed in February 2024.

Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...

Further diagnostic tests revealed that Charles has “a form of cancer.” In the months since the announcement, no further ...

That’s why it’s so important we speak openly about a cancer diagnosis. This year we have had a number of high profile men talking openly about their cancer. Cyclist Sir Chris Hoy, Duran Duran ...

This is the first time scientists have shown that a common type of drug resistance in prostate cancer can be reversed, not ...

A CHIPPING Sodbury man with terminal cancer is marking his 60th birthday with some inspiring charity challenges ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies ...

Treatments for prostate cancers localised to the prostate have long been aimed at treating the whole prostate either by ...